09:51 AM EDT, 08/23/2024 (MT Newswires) -- Applied DNA Sciences ( APDN ) rose by more than 30% in recent trading after the company said its subsidiary, Applied DNA Clinical Labs, has submitted a validation package to the New York State Department of Health seeking to expand the permitted use of its Linea Mpox Virus 1.0 Assay to include both mpox clade I and clade II.

The company said the validation studies concluded that the assay's primers and probe have 100% homology to mpox clade I and clade Ib. It said that the assay was approved in September 2022 by the department as a laboratory-developed test to detect mpox clade II.

Price: 2.08, Change: +0.25, Percent Change: +13.66